(Q36057340)

11 August 2017

The Role of receptor for Advanced Glycation End Products (RAGE) in the proliferation of hepatocellular carcinoma (English)

1 reference

11 August 2017

hepatocellular carcinoma

1 reference

Al-Madhagi Yaser

1

1 reference

11 August 2017

Yan Huang

2

1 reference

11 August 2017

Rong-Rong Zhou

3

1 reference

11 August 2017

Guan-Sheng Hu

4

1 reference

11 August 2017

Mei-Fang Xiao

5

1 reference

11 August 2017

Zhe-Bing Huang

6

1 reference

11 August 2017

Chao-Jun Duan

7

1 reference

11 August 2017

Wei Tian

8

1 reference

11 August 2017

Dao-Lin Tang

9

1 reference

11 August 2017

Xue-Gong Fan

10

1 reference

11 August 2017

language of work or name

English

0 references

publication date

18 May 2012

1 reference

International Journal of Molecular Sciences

11 August 2017

1 reference

11 August 2017

13

1 reference

11 August 2017

5

1 reference

11 August 2017

5982-5997

1 reference

Creative Commons Attribution 4.0 International

11 August 2017

start time

18 May 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

describes a project that uses

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC3382819/fullTextXML

inferred from PubMed Central ID database lookup

cites work

High-mobility group box 1 and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

Silencing alpha-fetoprotein expression induces growth arrest and apoptosis in human hepatocellular cancer cell

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

HMGB1: endogenous danger signaling

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

RAGE and RAGE ligands in cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

Receptor for AGE (RAGE): weaving tangled webs within the inflammatory response.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

A novel function of the receptor for advanced glycation end-products (RAGE) in association with tumorigenesis and tumor differentiation of HCC

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

Arguing for the motion: yes, RAGE is a receptor for advanced glycation endproducts

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

Masquerader: high mobility group box-1 and cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

Understanding RAGE, the receptor for advanced glycation end products

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

Colon cancer cell-derived high mobility group 1/amphoterin induces growth inhibition and apoptosis in macrophages

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

Transcription factors involved in development and progression of malignant melanoma.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

Differential effects between amphoterin and advanced glycation end products on colon cancer cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

N -Glycans on the receptor for advanced glycation end products influence amphoterin binding and neurite outgrowth

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

HMG1 and 2, and related 'architectural' DNA-binding proteins

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

NF-kappaB/rel/IkappaB: implications in gastrointestinal diseases

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

HMG-1 as a late mediator of endotoxin lethality in mice

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

NK-kappa B subunit-specific regulation of the I kappa B alpha promoter.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382819

Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging

23 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.3390%2FIJMS13055982

Variation of HMGB1 expression in breast cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22754344

12 December 2020

inferred from PubMed ID database lookup

Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22754344

12 December 2020

inferred from PubMed ID database lookup

RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22754344

12 December 2020

inferred from PubMed ID database lookup

Identifiers

1 reference

https://api.fatcat.wiki/v0/release/dzn7flycpjagbbss5benrax2by

30 July 2022

release_dzn7flycpjagbbss5benrax2by

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dzn7flycpjagbbss5benrax2by

30 July 2022

https://api.fatcat.wiki/v0/release/dzn7flycpjagbbss5benrax2by

1 reference

30 July 2022

https://api.fatcat.wiki/v0/release/dzn7flycpjagbbss5benrax2by

PubMed publication ID

1 reference

30 July 2022